Tokyo Tape
Sign in
← Hisamitsu Pharmaceutical Co

Annual report

4530.TEDINET S100VT69
Period2024-03-01 → 2025-02-28
Filed2025-05-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
MetricValuePeriodScopeSource row
Revenue¥156.0bn2024-03-01 → 2025-02-28Cons.Net sales
Revenue¥141.7bn2023-03-01 → 2024-02-29Cons.Net sales
Revenue¥128.3bn2022-03-01 → 2023-02-28dCons.Net sales (5-year summary)
Revenue¥120.2bn2021-03-01 → 2022-02-28dCons.Net sales (5-year summary)
Revenue¥114.5bn2020-03-01 → 2021-02-28dCons.Net sales (5-year summary)
Operating income¥18.9bn2024-03-01 → 2025-02-28Cons.Operating income
Operating income¥13.2bn2023-03-01 → 2024-02-29Cons.Operating income
Ordinary income¥24.0bn2024-03-01 → 2025-02-28Cons.Ordinary income
Ordinary income¥19.6bn2023-03-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥16.1bn2022-03-01 → 2023-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥12.6bn2021-03-01 → 2022-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥11.8bn2020-03-01 → 2021-02-28dCons.Ordinary income loss (5-year summary)
Profit before tax¥28.7bn2024-03-01 → 2025-02-28Cons.Income before income taxes
Profit before tax¥19.2bn2023-03-01 → 2024-02-29Cons.Income before income taxes
Net income (owners)¥21.8bn2024-03-01 → 2025-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥14.0bn2023-03-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.7bn2022-03-01 → 2023-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.7bn2021-03-01 → 2022-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.3bn2020-03-01 → 2021-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥22.3bn2024-03-01 → 2025-02-28Cons.Profit loss
Net income¥14.4bn2023-03-01 → 2024-02-29Cons.Profit loss
Total assets¥343.1bnat 2025-02-28Cons.Assets
Total assets¥328.8bnat 2024-02-29Cons.Assets
Total assets¥313.9bnat 2023-02-28dCons.Total assets (5-year summary)
Total assets¥302.9bnat 2022-02-28dCons.Total assets (5-year summary)
Total assets¥299.9bnat 2021-02-28dCons.Total assets (5-year summary)
Total liabilities¥63.7bnat 2025-02-28Cons.Liabilities
Total liabilities¥61.7bnat 2024-02-29Cons.Liabilities
Net assets / equity¥279.4bnat 2025-02-28Cons.Net assets
Net assets / equity¥267.1bnat 2024-02-29Cons.Net assets
Net assets / equity¥258.4bnat 2023-02-28dCons.Net assets
Net assets / equity¥254.9bnat 2022-02-28dCons.Net assets (5-year summary)
Net assets / equity¥253.8bnat 2021-02-28dCons.Net assets (5-year summary)
Cash and deposits¥114.5bnat 2025-02-28Cons.Cash and deposits
Cash and deposits¥112.5bnat 2024-02-29Cons.Cash and deposits
Cash & equivalents¥89.8bnat 2025-02-28Cons.Cash and cash equivalents
Cash & equivalents¥66.4bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥65.4bnat 2023-02-28dCons.Cash and cash equivalents
Cash & equivalents¥86.2bnat 2022-02-28dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥91.4bnat 2021-02-28dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥18.8bn2024-03-01 → 2025-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥18.2bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥12.7bn2022-03-01 → 2023-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥19.2bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.3bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow¥17.6bn2024-03-01 → 2025-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.5bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥23.9bn2022-03-01 → 2023-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13.1bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥7.8bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥15.8bn2024-03-01 → 2025-02-28Cons.Net cash provided by used in financing activities
Financing cash flow−¥16.7bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow−¥14.7bn2022-03-01 → 2023-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥15.2bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥7.2bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥295.572024-03-01 → 2025-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.622023-03-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥148.012022-03-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.922021-03-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥113.222020-03-01 → 2021-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥295.152024-03-01 → 2025-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥181.422023-03-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥147.882022-03-01 → 2023-02-28dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥118.842021-03-01 → 2022-02-28dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥113.112020-03-01 → 2021-02-28dCons.Diluted earnings per share (5-year summary)
Net assets per share¥3,788.47at 2025-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥3,492.62at 2024-02-29Cons.Net assets per share (5-year summary)
Net assets per share¥3,294.2at 2023-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥3,171.83at 2022-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥3,083.98at 2021-02-28dCons.Net assets per share (5-year summary)
Equity ratio80.6%at 2025-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio80.5%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio81.6%at 2023-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio83.5%at 2022-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio84.1%at 2021-02-28dCons.Equity to asset ratio (5-year summary)
ROE8.0%2024-03-01 → 2025-02-28Cons.Rate of return on equity (5-year summary)
ROE5.4%2023-03-01 → 2024-02-29Cons.Rate of return on equity (5-year summary)
ROE4.7%2022-03-01 → 2023-02-28dCons.Rate of return on equity (5-year summary)
ROE3.8%2021-03-01 → 2022-02-28dCons.Rate of return on equity (5-year summary)
ROE3.7%2020-03-01 → 2021-02-28dCons.Rate of return on equity (5-year summary)
Employees2,799at 2025-02-28Cons.Number of employees
Employees2,759at 2024-02-29Cons.Number of employees
Employees2,769at 2023-02-28dCons.Number of employees
Employees2,784at 2022-02-28dCons.Number of employees
Employees2,770at 2021-02-28dCons.Number of employees
Revenue¥102.6bn2024-03-01 → 2025-02-28StandaloneNet sales
Revenue¥96.6bn2023-03-01 → 2024-02-29StandaloneNet sales
Revenue¥93.0bn2022-03-01 → 2023-02-28dStandaloneNet sales (5-year summary)
Revenue¥90.6bn2021-03-01 → 2022-02-28dStandaloneNet sales (5-year summary)
Revenue¥86.7bn2020-03-01 → 2021-02-28dStandaloneNet sales (5-year summary)
Operating income¥13.7bn2024-03-01 → 2025-02-28StandaloneOperating income
Operating income¥10.7bn2023-03-01 → 2024-02-29StandaloneOperating income
Ordinary income¥16.5bn2024-03-01 → 2025-02-28StandaloneOrdinary income
Ordinary income¥14.2bn2023-03-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥14.1bn2022-03-01 → 2023-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥10.6bn2021-03-01 → 2022-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥10.4bn2020-03-01 → 2021-02-28dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥21.2bn2024-03-01 → 2025-02-28StandaloneIncome before income taxes
Profit before tax¥13.8bn2023-03-01 → 2024-02-29StandaloneIncome before income taxes
Net income¥16.4bn2024-03-01 → 2025-02-28StandaloneProfit loss
Net income¥9.9bn2023-03-01 → 2024-02-29StandaloneProfit loss
Net income¥10.4bn2022-03-01 → 2023-02-28dStandaloneNet income loss (5-year summary)
Net income¥7.2bn2021-03-01 → 2022-02-28dStandaloneNet income loss (5-year summary)
Net income¥8.3bn2020-03-01 → 2021-02-28dStandaloneNet income loss (5-year summary)
Total assets¥249.2bnat 2025-02-28StandaloneAssets
Total assets¥256.0bnat 2024-02-29StandaloneAssets
Total assets¥254.0bnat 2023-02-28dStandaloneTotal assets (5-year summary)
Total assets¥254.3bnat 2022-02-28dStandaloneTotal assets (5-year summary)
Total assets¥264.1bnat 2021-02-28dStandaloneTotal assets (5-year summary)
Total liabilities¥40.6bnat 2025-02-28StandaloneLiabilities
Total liabilities¥43.2bnat 2024-02-29StandaloneLiabilities
Net assets / equity¥208.6bnat 2025-02-28StandaloneNet assets
Net assets / equity¥212.8bnat 2024-02-29StandaloneNet assets
Net assets / equity¥214.5bnat 2023-02-28dStandaloneNet assets
Net assets / equity¥222.4bnat 2022-02-28dStandaloneNet assets (5-year summary)
Net assets / equity¥231.2bnat 2021-02-28dStandaloneNet assets (5-year summary)
Cash and deposits¥43.3bnat 2025-02-28StandaloneCash and deposits
Cash and deposits¥52.0bnat 2024-02-29StandaloneCash and deposits
EPS (basic)¥222.22024-03-01 → 2025-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥128.082023-03-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥131.212022-03-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥88.252021-03-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥102.072020-03-01 → 2021-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥221.882024-03-01 → 2025-02-28StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥127.932023-03-01 → 2024-02-29StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥131.12022-03-01 → 2023-02-28dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥88.192021-03-01 → 2022-02-28dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥101.972020-03-01 → 2021-02-28dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥902024-03-01 → 2025-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥852023-03-01 → 2024-02-29StandaloneDividend paid per share (5-year summary)
Dividend per share¥84.52022-03-01 → 2023-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥842021-03-01 → 2022-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥83.52020-03-01 → 2021-02-28dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,852.47at 2025-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥2,804.37at 2024-02-29StandaloneNet assets per share (5-year summary)
Net assets per share¥2,754.67at 2023-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,784.39at 2022-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,825.43at 2021-02-28dStandaloneNet assets per share (5-year summary)
Equity ratio83.5%at 2025-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.0%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2023-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.3%at 2022-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.5%at 2021-02-28dStandaloneEquity to asset ratio (5-year summary)
ROE7.8%2024-03-01 → 2025-02-28StandaloneRate of return on equity (5-year summary)
ROE4.6%2023-03-01 → 2024-02-29StandaloneRate of return on equity (5-year summary)
ROE4.8%2022-03-01 → 2023-02-28dStandaloneRate of return on equity (5-year summary)
ROE3.2%2021-03-01 → 2022-02-28dStandaloneRate of return on equity (5-year summary)
ROE3.7%2020-03-01 → 2021-02-28dStandaloneRate of return on equity (5-year summary)
Shares issued85,164,895at 2025-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2023-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2022-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2021-02-28dStandaloneTotal number of issued shares (5-year summary)
Employees1,488at 2025-02-28StandaloneNumber of employees
Employees1,506at 2024-02-29StandaloneNumber of employees
Employees1,521at 2023-02-28dStandaloneNumber of employees
Employees1,587at 2022-02-28dStandaloneNumber of employees
Employees1,583at 2021-02-28dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2025-02-2858 pure
Pharmaceutical Businessreportable segmentemployeesat 2025-02-282741 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,022
ItemContextValueUnit
Net assetsCurrentYearInstant_NonConsolidatedMember_RevaluationReserveForLandMember3337000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember21486000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember408000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember208618000000JPY
Freightage and packing expenses sgaPrior1YearDuration_NonConsolidatedMember2440000000JPY
Freightage and packing expenses sgaCurrentYearDuration_NonConsolidatedMember3218000000JPY
Advertisement expenses sgaPrior1YearDuration_NonConsolidatedMember9912000000JPY
Advertisement expenses sgaCurrentYearDuration_NonConsolidatedMember8935000000JPY
Promotion expenses sgaPrior1YearDuration_NonConsolidatedMember5546000000JPY
Promotion expenses sgaCurrentYearDuration_NonConsolidatedMember6080000000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration_NonConsolidatedMember3000000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration_NonConsolidatedMember9000000JPY
Salaries sgaPrior1YearDuration_NonConsolidatedMember4726000000JPY
Salaries sgaCurrentYearDuration_NonConsolidatedMember4821000000JPY
Bonuses sgaPrior1YearDuration_NonConsolidatedMember1412000000JPY
Bonuses sgaCurrentYearDuration_NonConsolidatedMember1354000000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember806000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember826000000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember182000000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember186000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember973000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember1317000000JPY
Taxes and dues sgaPrior1YearDuration_NonConsolidatedMember441000000JPY
Taxes and dues sgaCurrentYearDuration_NonConsolidatedMember572000000JPY
Contribution sgaPrior1YearDuration_NonConsolidatedMember50000000JPY
Contribution sgaCurrentYearDuration_NonConsolidatedMember36000000JPY
Business consignment expenses sgaPrior1YearDuration_NonConsolidatedMember1490000000JPY
Business consignment expenses sgaCurrentYearDuration_NonConsolidatedMember1592000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember6191000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember8311000000JPY
Provision for compensation research and development expenses sgaPrior1YearDuration_NonConsolidatedMember225000000JPY
Provision for compensation research and development expenses sgaCurrentYearDuration_NonConsolidatedMember221000000JPY
Retirement benefit expenses research and development expenses sgaPrior1YearDuration_NonConsolidatedMember55000000JPY
Retirement benefit expenses research and development expenses sgaCurrentYearDuration_NonConsolidatedMember51000000JPY
Depreciation expenses research and development expenses sgaPrior1YearDuration_NonConsolidatedMember316000000JPY
Depreciation expenses research and development expenses sgaCurrentYearDuration_NonConsolidatedMember1324000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-05-23
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第123期(自　2024年３月１日　至　2025年２月28日)
Company name cover pageFilingDateInstant
Original text (Japanese)久光製薬株式会社
Company name in english cover pageFilingDateInstantHISAMITSU PHARMACEUTICAL CO.,INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　中　冨　一　榮
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)佐賀県鳥栖市田代大官町408番地
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)0942(83)2101(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)上席執行役員BU本部長　　矢　野　栄
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内二丁目４番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(5293)1700(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役執行役員経営企画本部長　　磯　部　雄　一

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2024-02-29pass rounding
balance sheet identityconsolidated 2025-02-28pass
balance sheet identitynon_consolidated 2024-02-29pass rounding
balance sheet identitynon_consolidated 2025-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net assetsconsolidated 2025-02-28pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · net assetsnon_consolidated 2025-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2024-03-01/2025-02-28pass
statement vs summary · operating cash flowconsolidated 2023-03-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2024-03-01/2025-02-28pass
statement vs summary · revenueconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenueconsolidated 2024-03-01/2025-02-28pass
statement vs summary · revenuenon_consolidated 2023-03-01/2024-02-29pass
statement vs summary · revenuenon_consolidated 2024-03-01/2025-02-28pass
statement vs summary · total assetsconsolidated 2024-02-29pass
statement vs summary · total assetsconsolidated 2025-02-28pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass
statement vs summary · total assetsnon_consolidated 2025-02-28pass